| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0 (Miss by $-0.48) |
| EPS GAAP Actual | $0 (Miss by $-0.48) |
| Revenue Actual | $0.580437B |
| Revenue Surprise | Beat by $580.437M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.27 |
| EPS GAAP Estimate | $0.27 |
| Revenue Estimate | $0.552507B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.8 | 23.61 | 0.78309 | 0.82971 | 1 |
| Dec 2025 | 1.1 | 17.17 | 1.1 | 1.1 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.24 | 0.1 | 0.580437B | 15.31% | 109.96M |
| FQ2 2025 (Jun 2025) | 0.35 | 0.21 | 0.538165B | 8.93% | 67.69M |
| FQ1 2025 (Mar 2025) | 0.23 | 0.12 | 0.488627B | -2.47% | 21.87M |
| FQ4 2024 (Dec 2024) | 0.17 | 0.0075 | 0.479293B | -2.49% | -11.31M |
| FQ3 2024 (Sep 2024) | 0.19 | 0.0525 | 0.491558B | 1.6% | 11.33M |
| FQ2 2024 (Jun 2024) | 0.17 | -1.17259 | 0.490109B | 5.39% | -437.26M |
| FQ1 2024 (Mar 2024) | 0.08 | 0.08 | 0.500686B | 8.53% | 500.69M |
| FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 0.491246B | 100% | 491.25M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.27
Consensus Revenue Estimates
0.552507B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.44667 | -- | 0.43006 | 0.45669 | 1 |
| FQ3 2026 (Sep 2026) | 0.38 | 36.84 | 0.37135 | 0.38719 | 1 |
| FQ2 2026 (Jun 2026) | 0.35 | 0 | 0.34203 | 0.35662 | 1 |
| FQ1 2026 (Mar 2026) | 0.27 | 14.81 | 0.26024 | 0.27676 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.64B | -- | 0.62B | 0.65B | 2 |
| FQ3 2026 (Sep 2026) | 0.6B | 3.57 | 0.59B | 0.61B | 2 |
| FQ2 2026 (Jun 2026) | 0.58B | 6.65 | 0.57B | 0.58B | 2 |
| FQ1 2026 (Mar 2026) | 0.55B | 11.56 | 0.54B | 0.56B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.14 | 0.24 | 0.1 | 41.67% |
| FQ2 2025 (Jun 2025) | 0.14 | 0.35 | 0.21 | 60% |
| FQ1 2025 (Mar 2025) | 0.11 | 0.23 | 0.12 | 52.17% |
| FQ4 2024 (Dec 2024) | 0.1625 | 0.17 | 0.0075 | 4.41% |
| FQ3 2024 (Sep 2024) | 0.1375 | 0.19 | 0.0525 | 27.63% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.17 | -1.17259 | -689.76% |
| FQ1 2024 (Mar 2024) | 0.08 | 0.08 | 100% | |
| FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.47B | $0.58B | $109.96M | 18.94% |
| FQ2 2025 (Jun 2025) | $0.47B | $0.54B | $67.69M | 12.58% |
| FQ1 2025 (Mar 2025) | $0.47B | $0.49B | $21.87M | 4.48% |
| FQ4 2024 (Dec 2024) | $0.49B | $0.48B | $-11.31M | -2.36% |
| FQ3 2024 (Sep 2024) | $0.48B | $0.49B | $11.33M | 2.31% |
| FQ2 2024 (Jun 2024) | $0.93B | $0.49B | $-437.26M | -89.22% |
| FQ1 2024 (Mar 2024) | $0B | $0.5B | $500.69M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.49B | $491.25M | 100% |